WallStreetZenWallStreetZen

NASDAQ: THRD
Third Harmonic Bio Inc Stock

$9.44-0.03 (-0.32%)
Updated Mar 28, 2024
THRD Price
$9.44
Fair Value Price
$0.01
Market Cap
$384.34M
52 Week Low
$4.03
52 Week High
$11.60
P/E
-12.1x
P/B
1.43x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$30.82M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.03
Operating Cash Flow
-$20M
Beta
0.84
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

THRD Overview

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how THRD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

THRD ($9.44) is overvalued by 141,065.03% relative to our estimate of its Fair Value price of $0.01 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
THRD ($9.44) is not significantly undervalued (141,065.03%) relative to our estimate of its Fair Value price of $0.01 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
THRD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more THRD due diligence checks available for Premium users.

Be the first to know about important THRD news, forecast changes, insider trades & much more!

THRD News

Valuation

THRD fair value

Fair Value of THRD stock based on Discounted Cash Flow (DCF)
Price
$9.44
Fair Value
$0.01
Overvalued by
141,065.03%
THRD ($9.44) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
THRD ($9.44) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
THRD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

THRD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-12.1x
Industry
14.26x
Market
44.51x

THRD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.43x
Industry
6.21x
THRD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

THRD's financial health

Profit margin

Revenue
$0.0
Net Income
-$6.8M
Profit Margin
0%
THRD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$277.7M
Liabilities
$8.6M
Debt to equity
0.03
THRD's short-term assets ($272.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
THRD's short-term assets ($272.45M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
THRD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.6M
Investing
-$1.0k
Financing
$798.0k
THRD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

THRD vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
THRD$384.34M-0.32%-12.10x1.43x
AKBA$383.15M-18.30%-6.54x-12.53x
RENB$380.72M-5.02%-3.79x8.73x
TCRX$380.18M-4.34%-5.84x2.52x
MNMD$388.54M-1.05%-3.85x4.97x

Third Harmonic Bio Stock FAQ

What is Third Harmonic Bio's quote symbol?

(NASDAQ: THRD) Third Harmonic Bio trades on the NASDAQ under the ticker symbol THRD. Third Harmonic Bio stock quotes can also be displayed as NASDAQ: THRD.

If you're new to stock investing, here's how to buy Third Harmonic Bio stock.

What is the 52 week high and low for Third Harmonic Bio (NASDAQ: THRD)?

(NASDAQ: THRD) Third Harmonic Bio's 52-week high was $11.60, and its 52-week low was $4.03. It is currently -18.62% from its 52-week high and 134.24% from its 52-week low.

How much is Third Harmonic Bio stock worth today?

(NASDAQ: THRD) Third Harmonic Bio currently has 40,714,399 outstanding shares. With Third Harmonic Bio stock trading at $9.44 per share, the total value of Third Harmonic Bio stock (market capitalization) is $384.34M.

Third Harmonic Bio stock was originally listed at a price of $18.00 in Sep 16, 2022. If you had invested in Third Harmonic Bio stock at $18.00, your return over the last 1 years would have been -47.56%, for an annualized return of -47.56% (not including any dividends or dividend reinvestments).

How much is Third Harmonic Bio's stock price per share?

(NASDAQ: THRD) Third Harmonic Bio stock price per share is $9.44 today (as of Mar 28, 2024).

What is Third Harmonic Bio's Market Cap?

(NASDAQ: THRD) Third Harmonic Bio's market cap is $384.34M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Third Harmonic Bio's market cap is calculated by multiplying THRD's current stock price of $9.44 by THRD's total outstanding shares of 40,714,399.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.